Our mission is to improve the lives of patients by developing novel, best-in-class treatments to address some of the most important unmet patient needs. We aim to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology, making our products:
- More effective than other pharmaceutical agents in the same class
- Safer or better tolerated than other pharmaceutical agents in the same class
- Better able to address the multiple pathways of a disease or disorder through new mechanisms of action and delivery
- Potentially able to reduce the dependence on other classes of drugs with more harmful side effects, such as opioids
Also, by applying our technologies to already-approved pharmacological agents and utilizing the 505(b)(2) regulatory pathway, we seek to potentially accelerate the development and lower the clinical and regulatory risk of our product candidates.